Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based on our own technology platforms for the selection of active molecules – antibodies and aptamers.
Pure Biologics also offers commercial partnership options in several areas including early phase biological drug discovery and development, selection and characterization of antibodies and aptamers, as well as protein production, purification and analysis.
Duńska 11, 54-427 Wrocław – Poland
Dec. 1, 2018Stock exchange(s)
Warsaw Stock Exchange